Concepedia

Publication | Open Access

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

DOIFull Paper Access

59

Citations

24

References

2019

Year

Abhishek S. Kashyap, Tamara Thelemann, Richard Klar, Sandra M. Kallert, Julia Festag, Mélanie Buchi, Lisa Hinterwimmer, Monika Schell, Sven Michel, Frank Jaschinski,
Journal for ImmunoTherapy of Cancer

Abstract

Targeting of CD39 by ASOs represents a promising state-of-the art therapeutic approach to improve immune responses against tumors.

References

YearCitations

Page 1